Aida Pharmaceuticals, Inc. (AIDA)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Aug 5, 2025
Aida Pharmaceuticals Market Cap
Aida Pharmaceuticals has a market cap or net worth of $5.40 thousand as of August 20, 2025. Its market cap has decreased by -98.99% in one year.
Market Cap
5.40K
Enterprise Value
n/a
Revenue
40.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since December 16, 2005, Aida Pharmaceuticals's market cap has decreased from 36.25M to 5.40K, a decrease of -99.99%. That is a compound annual growth rate of -36.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 5.40K | -98.57% |
| Dec 31, 2020 | 378.00K | -44.00% |
| Dec 14, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 815.18M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 614.68M |
| Glass House Brands | 554.44M |
| American Oncology Network | 385.65M |
| CytoDyn | 360.07M |
| Northwest Biotherapeutics | 355.76M |